Related Experiment Videos
Holmium laser sclerostomy: a clinical study
1Prince Charles Eye Unit, King Edward VII Hospital, Windsor, UK.
Eye (London, England)
|January 1, 1993
Summary
Holmium laser sclerostomy effectively reduced intraocular pressure in glaucoma patients, achieving a 70% success rate. This office procedure shows promise as an alternative to traditional glaucoma surgeries.
Area of Science:
- Ophthalmology
- Surgical Innovation
Background:
- Glaucoma management often requires surgical intervention to lower intraocular pressure.
- Traditional glaucoma surgeries like trabeculectomy carry risks and may not be suitable for all patients.
Purpose of the Study:
- To evaluate the efficacy and safety of ab externo holmium laser sclerostomy in treating glaucoma.
- To assess the potential of this laser technique as a primary or adjunctive glaucoma treatment.
Main Methods:
- A prospective study involving 30 glaucoma patients undergoing ab externo holmium laser sclerostomy.
- Intraocular pressure was measured pre-operatively and post-operatively.
- Success was defined by strict criteria, and complications were recorded.
Main Results:
- Successful filtering bleb formation required an average of 40.2 pulses at 100 mJ.
- Mean intraocular pressure decreased from 25.5 mmHg pre-operatively to 14.06 mmHg post-operatively.
- 70% of procedures were successful at a mean follow-up of 7.5 months.
- Iris plugging occurred in some cases but was successfully treated with neodymium:YAG laser in 80%.
Conclusions:
- Ab externo holmium laser sclerostomy is a promising, quick, and potentially office-based procedure for glaucoma.
- It may serve as an alternative to trabeculectomy or an additional option for complex cases.
- Long-term efficacy requires further evaluation.